A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status

NCT02831842 · clinicaltrials.gov ↗

COMPLETED

Status

4278

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Anti-EGFR-Containing Regimen
DRUG: Bevacizumab-containing regimen
DRUG: Chemotherapy

Sponsor

Hoffmann-La Roche